Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effects of realgar (As4S4) on degradation of PML-RARA harboring acquired arsenic-resistance mutations

Published:2017-08-18 Issue:11 Volume:96 Page:1945-1948
ISSN:0939-5555
Container-title:Annals of Hematology
language:en
Short-container-title:Ann Hematol

Author:

Niu Mingshan,Shen Yangling,Qi Jialei,Liu Xuejiao,Sang Wei,Wu Qingyun,Cao Jiang,Chen Wei,Yao Yao,Xu Kailin

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s00277-017-3093-8/fulltext.html

Reference10 articles.

1. Zeng C, Yu X, Lai J, Yang L, Chen S, Li Y (2015) Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia. J Hematol Oncol 8:126

2. Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S et al (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med 369:111–121

3. Zhu HH, Qin YZ, Huang XJ (2014) Resistance to arsenic therapy in acute promyelocytic leukemia. N Engl J Med 370:1864–1866

4. Lou Y, Ma Y, Sun J, Ye X, Pan H, Wang Y et al (2015) Evaluating frequency of PML-RARA mutations and conferring resistance to arsenic trioxide-based therapy in relapsed acute promyelocytic leukemia patients. Ann Hematol 94:1829–1837

5. Zhu HH, Wu DP, Jin J, Li JY, Ma J, Wang JX et al (2013) Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial. J Clin Oncol 31:4215–4221

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acid Water-ground Nano-realgar Is Superior to Crude Realgar in Promoting Apoptosis of MCF-7 Breast Cancer Cells;Current Medical Science;2022-07-05

2. Temperature-sensitive gel-loaded composite nanomedicines for the treatment of cervical cancer by vaginal delivery;International Journal of Pharmaceutics;2020-08

3. MiR-340 Is a Biomarker for Selecting Treatment Between Chemotherapy and Allogeneic Transplantation in Acute Myeloid Leukemia;Frontiers in Oncology;2019-10-11

4. High expression of miR-25 predicts favorable chemotherapy outcome in patients with acute myeloid leukemia;Cancer Cell International;2019-05-07

5. High expression of miR‐338 is associated with poor prognosis in acute myeloid leukemia undergoing chemotherapy;Journal of Cellular Physiology;2019-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3